🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 3 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/01/2026 21,92 22,00 21,20 21,31 -0,98% 3,65% 1.896.100
31/12/2025 21,45 21,77 21,33 21,52 +0,14% 2,05% 1.845.200
30/12/2025 21,79 21,91 21,40 21,49 -1,51% 2,34% 2.088.100
29/12/2025 21,81 21,96 21,36 21,82 -1,36% 2,75% 2.669.600
26/12/2025 22,36 22,41 21,86 22,12 -0,90% 2,46% 1.392.500
24/12/2025 21,96 22,46 21,82 22,32 +1,45% 2,91% 1.254.200
23/12/2025 21,19 22,52 21,10 22,00 +3,63% 6,70% 2.784.500
22/12/2025 20,87 21,53 20,86 21,23 +0,90% 3,21% 2.314.700
19/12/2025 20,33 21,48 20,33 21,04 +3,44% 5,66% 6.507.600
18/12/2025 21,15 21,64 20,14 20,34 -3,78% 7,09% 2.381.500
17/12/2025 22,29 22,42 21,06 21,14 -5,24% 6,10% 2.540.400
16/12/2025 21,49 22,97 21,35 22,31 +3,53% 7,54% 3.644.500
15/12/2025 21,88 22,34 20,93 21,55 +0,09% 6,44% 3.230.900
12/12/2025 21,72 21,74 21,18 21,53 -1,01% 2,58% 2.008.800
11/12/2025 21,08 21,96 20,76 21,75 -2,03% 5,69% 4.775.500
10/12/2025 22,11 22,67 21,84 22,20 +0,14% 3,75% 3.103.500
09/12/2025 22,46 22,85 21,85 22,17 +1,42% 4,45% 2.223.200
08/12/2025 22,53 22,67 21,44 21,86 -1,80% 5,46% 3.809.600
05/12/2025 22,89 22,93 21,95 22,26 -2,45% 4,28% 2.659.300
04/12/2025 21,55 23,00 21,47 22,82 +4,49% 7,10% 3.396.000
03/12/2025 19,75 21,93 19,43 21,84 +6,69% 12,66% 3.472.700
02/12/2025 19,82 20,53 19,37 20,47 +3,80% 5,85% 4.003.900
01/12/2025 20,85 21,00 19,67 19,72 -7,59% 6,38% 2.857.500
28/11/2025 21,12 21,38 20,72 21,34 +1,86% 3,13% 1.633.000
26/11/2025 19,40 21,21 19,35 20,95 +8,27% 9,59% 3.246.900
25/11/2025 18,91 19,45 18,73 19,35 +2,33% 3,81% 3.000.100
24/11/2025 17,76 19,14 17,62 18,91 +6,90% 8,56% 4.427.300
21/11/2025 16,40 17,72 16,33 17,69 +7,34% 8,48% 3.939.900
20/11/2025 16,69 17,60 16,31 16,48 +0,55% 7,73% 4.640.000
19/11/2025 17,41 17,43 15,94 16,39 -6,02% 8,56% 4.398.200